The code of life is now editable and the question humanity must answer in the 2020s is not whether we can rewrite it—but whether we should, and for whom.

As of Tuesday, December 09, Senti Biosciences, Inc.’s SNTI share price has surged by 11.51%, which has investors questioning if this is right time to sell.

The Food and Drug Administration this week granted approval to a new gene therapy for a rare immune disorder, the maker of which is notably not a drug ...

The Commissioner’s National Priority Voucher program was launched in June to shorten review times for companies that align ...

A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life after treatment.

Friedreich’s ataxia is a genetic disorder that causes progressive damage to the nervous system and brain, leading to a loss ...

FDA approves 1st gene therapy for Wiskott-Aldrich syndrome, offering a new treatment for patients lacking matched stem cell donors.

EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million in a Series A financing ...

A pioneering genetic treatment is saving lives where chemotherapy failed, offering new hope for children and adults with aggressive leukemia. This world-first therapy has kept patients disease-free ...

Since the identification of Apolipoprotein E (APOE) ε4 as the strongest genetic risk factor for Alzheimer's Disease (AD), it has served as a critical marker for predicting disease susceptibility.

Lindberg had Parkinson’s disease, the neurologist said, with all the classic symptoms. PD—as the scientists she would meet ...

Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy December 9, 2025 3:00 ...